Capri­cor to be­gin fil­ing DMD drug with FDA next month; Sur­rozen’s $10M mile­stone

Plus, news about Adap­ti­m­mune, Roche, LifT Bio­Sciences, Ver­Im­mune, and Re­vance Ther­a­peu­tics:

Capri­cor Ther­a­peu­tics to file Duchenne car­diomy­opa­thy treat­ment with the FDA: The San Diego-based biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER